1123194-98-8 | 6-Bromo-2-methoxy-3-(4-methyl-1h-imidazol-1-yl)pyridine

Packsize	Purity	Availability	Price	Discounted Price
250mg	95%	in stock	$48.00	$34.00
1g	95%	in stock	$72.00	$51.00
5g	95%	in stock	$346.00	$242.00
25g	95%	in stock	$1,098.00	$768.00

Description

• Catalog Number: AB52427
• Chemical Name: 6-Bromo-2-methoxy-3-(4-methyl-1h-imidazol-1-yl)pyridine
• CAS Number: 1123194-98-8
• Molecular Formula: C10H10BrN3O
• Molecular Weight: 268.1099
• MDL Number: MFCD19690830
• SMILES: COc1nc(Br)ccc1n1cnc(c1)C

Computed Properties

• Complexity: 217
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 15
• Hydrogen Bond Acceptor Count: 3
• Rotatable Bond Count: 2
• XLogP3: 2.3

Upstream Synthesis Route

6-Bromo-2-methoxy-3-(4-methyl-1H-imidazol-1-yl)pyridine is a versatile compound that finds its main application in chemical synthesis processes, specifically in the field of medicinal chemistry. This compound is commonly utilized as a key building block for the preparation of various biologically active molecules, including pharmaceutical drugs and agrochemicals.One of the primary uses of 6-Bromo-2-methoxy-3-(4-methyl-1H-imidazol-1-yl)pyridine is in the synthesis of heterocyclic compounds. Its unique chemical structure featuring a pyridine ring fused with an imidazole moiety makes it a valuable intermediate for the creation of complex heterocyclic scaffolds. These heterocycles are frequently found in bioactive compounds and are essential for drug discovery and development.Moreover, the bromo and methoxy substituents on the pyridine ring of this compound can serve as functional handles for further derivatization and modification. Chemists can leverage these functional groups to introduce additional substituents or linkers to tailor the compound's properties or enhance its activity in a desired biological pathway.Overall, the strategic placement of functional groups in 6-Bromo-2-methoxy-3-(4-methyl-1H-imidazol-1-yl)pyridine makes it a valuable tool for chemical synthesis, particularly in the design and synthesis of new pharmaceutical agents and bioactive molecules.